Pure Health Holding is the largest vertically integrated healthcare service provider in the UAE with a cross-category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, healthcare tech and procurement, with a presence in the US and the UK.
The group operates as a holding company for 61 subsidiaries covering six business verticals, and some of its prominent subsidiaries include SEHA, Daman, Yas Clinic, Tamouh Healthcare, Ambulatory Healthcare Services, Pure Lab, One Health, Rafed, One Health, The Life Corner Pharmacy and Abu Dhabi Stem Cells Center.
Pure Health Holding is the largest healthcare group in the UAE, operating hospitals, pharmacies, health insurance, diagnostics, research centres, and procurement under a single umbrella. It is ranked number one across all its business verticals. Pure Health covers a network of 23 hospitals, 58+ clinics, 148 labs, 21K+ employees, covering 150+ specialities and with 52mn+ claims processed and 2.8mn+ insured members. The Group is expanding its footprints in the international market with a completed acquisition of a minority stake in Ardent Health Services US, and with an agreement in place to acquire 100% stake in Circle Health Group UK.
Pure Health Holding intends to sell 1.1mln new shares (constituting 10% of the post-IPO share capital of the company) at a fixed price of AED3.26/sh. The Group intends to raise AED3.6bn of fresh capital to finance new growth opportunities, including the acquisition of healthcare assets within and outside of the UAE. The IPO offers a fantastic opportunity to invest in the UAE’s largest integrated healthcare service provider at an attractive valuation of pre-IPO 2023e PE of 14.4x and 2023e EV/EBITDA of 10.0x.
